Infections'
The main achievement of this symposium was the breadth of scientific contact achieved not only between US and European workers in the same field, but between workers of different specialties (venereologists, ophthalmologists, epidemiologists, pediatricians, veterinarians, and mic- robiologists) who rarely meet jointly to describe their objectives and problems to each other or to establish mutual grounds for future research. Forty-six formal papers were presented by invited speakers representing all these scientific disciplines, together with many shorter communications and very extensive general discussion in which the 50 or more participants of the conference played a very active role. These general participants ranged from members of international and national health authorities to young clinicians and laboratory workers just beginning to work in this field. Thus the conference was able to fulfil one of its original basic functions, to provide a continuing education programme, in addition to meeting its later remit of presenting an up-to-date, intensive and specialized review of all aspects of work in this field for those already involved in one specific role.
Much of the success of the conference was undoubtedly due to its venue, and to the decision not to hold concurrent sessions for different types of specialist. The W Alton Jones Cell Science Center is most unusual in that it offers first-class facilities for such a convention in a small township in a rural area many miles from any major city. Thus there was a high degree of natural selection of those with the incentive to come to the meeting, an unprecedented cross-attendance of clinicians to all the laboratory workers' sessions and vice versa (to the benefit of both) and an extremely high survival rate throughout each long working day with much informal discussion throughout meals and late into 1 Symposium held 28-30 April 1976, Lake Placid, New York, USA, under the auspices of The National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA, and the W Alton Jones Cell Science Center (see Hobson & Holmes 1977, in press ). the evenings. A heavy April snowfall contributed to this togetherness.
Clinical Considerations
The first objective of the meeting was to establish the nature and extent of the clinical problems.
The incidence of nongonococcal urethritis (NGU) in the male has risen by 130 % in the US over the last 10 years and there are now an estimated 300 000 new cases each year. In Britain in 1974 there were 71 000 new male cases of NGU as against 38 500 new cases of gonorrhoea. Epidemiologically and clinically NGU can mimic gonorrhea sufficiently to cause diagnostic confusion, but occurs in a wider range of the population, and particularly in higher socio-economic groups less likely to be channelled through public sexually transmitted disease (STD) clinics than the traditional gonorrhaea patients. In the male, the complications and sequelae of NGU may resemble those of gonorrhoea, e.g. proctitis, epididymitis, and possibly prostatitis, but unlike gonorrhoea, can be the precursor of Reiter's syndrome, especially in patients of HLA 27 tissue type (over 30% of patients with Reiter's syndrome have had associated Chlamydia trachomatis infections). In women, especially in contacts of men with NGU, infection can be prolonged and relatively silent, although it is frequently associated with hypertrophic cervical erosions and mucopurulent cervicitis. Women are thus a persistent reservoir of infection. Again as in gonorrhoea, NGU may have serious sequele, e.g. salpingitis and pelvic inflammatory disease, especially in the puerperium, in addition to long-term theoretical risks such as carcinoma of the cervix. The rising incidence of nongonococcal genital infections has been accompanied by an increased frequency of nonbacterial conjunctivitis in the patients themselves, and particularly in infants born of infected women. These nongonococcal conditions do not respond quickly, if at all, to the regimes of antimicrobial therapy that have long been established as effective cures for gonorrhoea. However, it is generally accepted that treatment, especially of infected women and babies, is essential. These nongonococcal conditions are almost certainly of multiple etiology, but viruses such as herpes simplex and cytomegalovirus are infrequent, and bacteria or mycoplasma rare, as the main or sole etiological agents. The role of ureaplasmas remains uncertain until more sensitive and quantitative methods of culture become established, along with modem immunological developments, to differentiate normal carriers of these organisms from infected cases. Five papers and extensive discussion were devoted to the physiology and mode of interaction of these agents with eukaryotic cells, and their antigenic analysis. It has, however, clearly been shown that experimental infection of human volunteers with ureaplasmas can induce severe urethritis. The agent most frequently found in NGU syndromes is C. trachomatis. Despite geographical and demographic differences and differences in the detail of laboratory methods, most centres in the US and Britain where these syndromes have been extensively investigated find a remarkably similar incidence of C. trachomatis isolation: approximately 50 % of males with NGU and 30 % of their female consorts (together with 35 % of newborn babies with mucopurulent conjunctivitis in one selected series) have C. trachomatis as the sole or predominant pathogen.
The definition of the clinical problem and the demonstration that C. trachomatis occurred so frequently in NGU, &c. raised questions of obvious fundamental importance which were to be the main topics of the rest of the conference:
(1) To what extent does C. trachomatis in NGU fulfil Koch's postulates? Can it be accepted as the primary pathogen, or is it merely an opportunistic secondary invader?
(2) What is the relationship of the chlamydia isolated from NGU, &c. in temperate countries and strains of C. trachomatis found in endemic trachoma of tropical countries? Are genital strains ofchlamydia distinct from the agent of lymphogranuloma venereum (LGV)?
(3) If C. trachomatis is a causal agent, found in 30-50% of cases of NGU, &c., does this mean that present laboratory methods are insufficiently sensitive, and are failing to diagnose C. trachomatis infection in the remaining 50% of NGU cases? (4) If C. trachomatis causes a significant proportion of NGU, &c., how can it best be treated? (5) Can a satisfactory experimental animal model of C. trachomatis infection be devised for the closer study of pathogenesis, treatment and immune responses?
Endemic Trachoma It was extremely valuable that one session of papers and much of the general discussion was contributed by experts in the field of endemic trachoma. Controlled clinical and epidemiological surveys in the Middle and Far East, with supportive laboratory investigations, provided data which were highly relevant to problems now posed by chlamydia in their 'new' role as genital pathogens, e.g. (a) the effect of reinfection and of superinfection with other organisms; (b) the correlation of clinical pathology with the degree and stage of infection; (c) the influence of immune mechanisms, including delayed hypersensitivity; (d) the transmissibility and incidence of mixed infections with different serotypes of C. trachomatis; (e) the influence of 'socio-economic' circumstances on the frequency and outcome of infection; (f) rapid diagnostic methods; and (g) response to chemotherapy.
Role of C. trachomatis as a Pathogen in Genital Disease
The agent is found in >40 % of males with active NGU but in less than 2 % of comparable groups of sexually active males without urethritis. Antibody to C. trachomatis is closely correlated in frequency, class and titre with C. trachomatis (C.t) isolation ratesmost men with a primary clinical attack show fresh serological conversion, and most antibody is in the IgM class. Sixty per cent of female contacts of males with C.t-positive NGU have C. trachomatis infection of the cervix but only 5 % of consorts of males with C.t-negative NGU were C.t-positive. Serum antibody titres correspond closely with C. trachomatis isolation rates, but it is most important to look for seroconversion or the presence of recent IgM antibody. In any sexually active group of patients with 'background noise' of antibody due to previous infection is high.
These facts suggest that demonstrable C. trachomatis infection in the male with acute NGU is not simply reactivation of a long-standing resident organism by some other infecting agent. In the female the frequency of C. trachomatis isolation is correlated with the severity of clinical signs and symptoms. Although C. trachomatis may be found simultaneously with gonococci in the genital tract of both sexes and in the eye of neonates C. trachomatis is frequently the sole pathogen isolated. Specific treatment of the chlamydial infection with tetracyclines, erythromycin or sulphonamides causes rapid disappearance of signs and symptoms, such as conjunctivitis, urethritis or hypertrophic cervical erosion in C.tpositive cases, but is not effective in C.t-negative patients. Treatment with penicillin or aminoglycosides, which are effective in gonococcal and ureaplasma infections respectively, do not usually eradicate C. t-positive infection, and signs and symptoms persist. The so-called 'male postgonococcal syndrome', frequently described in the past, seems to be largely the result of undiagnosed concurrent C. trachomatis infection not responding to the penicillin regime which is curative for gonorrhaea. In infection of the eye, genital strains of C. trachomatis can result in micropannus and scarring indistinguishable from that found in endemic trachoma. The standard nonspecific regimes of neomycin and chloramphenicol used routinely to treat 'sticky eye' are ineffective. The more gross scarring of endemic trachoma may well be due to a combination of factors in which trauma, and poor hygiene, with secondary bacterial infection play an obvious role, but in which repeated C. trachomatis infection with superaddition of delayed hypersensitivity responses may be of prime importance. All these facts imply that, as in endemic trachoma, C. trachomatis infecting the eye or genital tract of patients in temperate countries is a primary pathogen, not a secondary invader.
Relation of Genital Strains of C. trachomatis to Other Chlamydia
Chlamydial antigens can now be identified and separated with a high degree of precision by chemical fractionation and electrophoresis, and these purified reagents can be used to prepare monospecific antisera. Twelve serotypes of C. trachomatis have now been identified. Types A, B and C account for most cases of endemic trachoma, whereas ocular and genital infections of temperate countries are predominantly due to types D, E, F. Only one of 18 type-specific antigens identified in C. trachomatis can be detected in LGV agent. The genital infections caused by C. trachomatis and LGV are distinctly different clinically and epidemiologically, the two agents behave quite differently in chick embryo and in tissue culture, and there is virtually no cross-serological activity other than that due to the common lipopolysaccharide group antigen of chlamydia which may be detected in complement fixation tests with unrefined antigens.
Results with the micro-immunofluorescence test and with a tissue culture indirect immunofluorescence test were discussed in relation to the new details of antigenic constitution in chlamydia, and their role in diagnosis is considered elsewhere in this account.
Laboratory Methodsfor the Isolation of C. trachomatis and Their Evaluation
The isolation of C. trachomatis in the yolk sac of chick embryo has now been almost entirely superseded by tissue culture (TC) isolation methods whereby the inoculated infective particles produce intracytoplasmic inclusions in the TC cells which can readily be seen when the monolayer is stained and examined microscopically 48-72 hours after inoculation. Previous work had suggested that sufficient sensitivity could only be achieved by using the McCoy line (then believed to be human synovial cells) which had been rendered nonreplicating by pretreatment with high dosage of irradiation. The general conclusion of this conference was that this method was not unique, though for technical reasons it might still be the method of choice in many laboratories. C. trachomatis will grow in a variety of cell lines derived from primates or non-primates. (McCoy cells are now known to be mouse fibroblasts resembling the mouse L cell tumour line.) Nonreplicating TC monolayers can be produced by chemical inhibitors such as deoxyuridine as well as by X-irradiation, but equally good results can be achieved with normal replicating cultures of McCoy or of the HeLa 229 line. The main difficulty in isolating C. trachomatis is the poor uptake of infective particles by the cell, and a poor 'efficiency of plating' of those taken up. Centrifugation and/or pinocytosis-promoting agents, e.g. DEAE Dextran, will improve adsorption, and the inclusion/input particle ratio can be improved by careful control of laboratory conditions, especially the constitution and quality of the TC medium, pH, temperature. There was general agreement that all the published methods could give similar sensitive results, i.e. C. trachomatis isolation rates of approximately 50 % of male NGU and 30 % of female nongonococcal STD, if attention is paid to the quality of the clinical specimens taken. Inclusion counts are high and reproducible, and in approximately 800% of patients, isolation of the agent is accompanied by seroconversion, or by high titres of IgM antibody. A large percentage of patients with C.t-negative nongonococcal conditions are found whichever TC method is used, and only about 50% of these patients have C. trachomatis antibody. It may be concluded that if any of the present methods are used efficiently, few STD patients with C. trachomatis infection will be missed. Simple swabs are as efficient as traumatic scraping methods. In conjunction with bacteriological and virological examination, these methods are helping to delineate an important field for future investigation, i.e. syndromes of nongonococcal nonchlamydial STD, where it is already certain that ureaplasmas, herpesvirus or cytomegalovirus play very little part.
Antibiotic Sensitivity of Chlamydia
In this section of the proceedings, it was of particular value that the fundamental biology of chlamydia, e.g. the nature of their cell wall, their enzyme systems and their complex developmental cycle could be discussed together with papers on (a) the essentially empirical use of antibiotics in the field against endemic trachoma and C. trachomatis genital infections, and (b) recent laboratory attempts to devise methods of guidance and control comparable to those in conventional bacteriology laboratories.
All C. trachomatis strains are sensitive to a wide variety of antibacterial agents. This can be assessed quantitatively in tissue culture systems by determination of the dosage required to give a standard reduction in the inclusion count. There appears to be little difference in sensitivity within or between the various serotypes of C. trachomatis. They do not readily acquire resistance to antibiotics after inadequate therapy in the patient or after deliberate passage through TC containing subinhibitory levels of antibiotics.
The tetracyclines and macrolides are the most effective group but C. trachomatis is resistant to aminoglycosides and vancomycin. The effect of penicillin is complex, and it appears to behave as a 'chlamydiostatic' rather than 'chlamydicidal' agent. This is probably because C. trachomatis can replicate within the cell as far as its initial body stage which does not have a cross-linked cell wall rich in peptidoglycans, but cannot develop into fully infective elementary bodies which do have this penicillin-sensitive structure. The removal of penicillin may allow previously arrested initial bodies to resume maturation. These findings may explain the frequent failure to eradicate C. trachomatis infection in patients treated only with the single-dose penicillin regimes customarily used for gonorrhoea.
Experimental Model Infections
The experimental infection of the eye of baboons and of blind human volunteers with C. trachomatis strains from endemic trachoma or from genital infections is historically well known. More recently, experimental pathologists have concentrated on establishing an animal model of genital C. trachomatis infections. Guineapigs may be infected with C. psittaci, and kittens with the naturally-pathogenic cat agent KC related to C. psittaci. A persistent urethritis or cervicitis can be established from which cell scrapings show abun-dant inclusions. The development of antibody both local and in serum can be demonstrated and correlated with resistance to challenge reinfection. A particular value of these model infections is that the effect of simultaneous or secondary deliberate infection with bacteria on C. trachomatis infections, and vice versa, can be studied quantitatively. Intraurethral inoculation of macaque monkeys with genital strains of C. trachomatis itself may provide a closer parallel to human NGUpersistent urethritis for periods of up to 10 weeks has been established, which offers opportunities for further study of latency and reactivation, response to antibiotics, and immune responses.
Other Manifestations ofC. trachomatis Infections in Humans
The number of C. trachomatis particles recoverable from simple eye swabs from patients with conjunctivitis may range from 10 000 to >60 000. It is thus probable that direct eye-to-eye spread may occur, as in endemic trachoma, in overcrowded unhygienic conditions, e.g. in schools. The heavy infection of tears makes it probable that nasopharyngeal infection will also occur. , C. trachomatis has been postulated as a cause of middle-ear disease and rhinitis in children. In neonates with C. trachomatis-positive ophthalmia, the agent has been recovered from bronchial secretions and throat swabs, and in a small series, frank lower-respiratory disease, 'pertussoid eosinophilic pneumonia', was manifest. This summary of a symposium of 46 papers is perforce a somewhat selective overview of its content.
The complete proceedings will be published early in 1977 (Hobson & Holmes, in press 
